SRDX Profile
Surmodics, Inc., based in Eden Prairie, Minnesota, specializes in advanced performance coating technologies for medical devices and chemical and biological components used in diagnostic tests globally. Founded in 1979, the company operates through two distinct segments: Medical Device and In Vitro Diagnostics (IVD).
The Medical Device segment focuses on enhancing medical device functionality through surface modification coating technologies. These innovations improve the access, deliverability, and deployment precision of intravascular devices. Additionally, Surmodics develops drug-delivery coatings that enable targeted drug release from medical device surfaces, catering to markets such as coronary, peripheral, neuro-vascular, and structural heart interventions. The segment also manufactures a range of vascular intervention devices, including drug-coated balloons and mechanical thrombectomy devices.
In the IVD segment, Surmodics specializes in the production and sale of chemical and biological components used in in vitro diagnostic immunoassays and molecular tests. This includes protein stabilizers, substrates, surface coatings, and antigens essential for diagnostic and biomedical research applications. The company leverages its expertise in precision coating technologies to enhance the accuracy and reliability of diagnostic tests across diverse medical disciplines.
With a commitment to innovation and quality, Surmodics serves a global customer base comprising medical device manufacturers, diagnostic laboratories, and biomedical research institutions. The company continues to advance its technological capabilities and expand its product portfolio to meet evolving market demands in healthcare and diagnostics.
|
